About Azakem Labs
Azakem Labs was a Healthcare company based in Hyderabad (India) founded in 2005 by A Prashant and K S Chowdary. Azakem Labs produces active pharmaceutical ingredients and intermediates. It operates on a B2B model. The company has 80 employees. Its Indian entity Azakem Labs Private Limited reported revenue of ₹47.09 Cr. The company is recorded as dissolved. Azakem Labs offers products and services including Almotriptan Malate, Eletriptan Hydrobromide, Anastrozole, API Manufacturing, and Research and Development. Its focus areas include Pharmaceuticals, Research and Development, Analytical Method Development and API Manufacturing. Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.
Company details
Azakem Labs Private Limited, established in 2005, is a manufacturing company specializing in active pharmaceutical ingredients and their intermediates for categories like anti-migraine and anti-bacterial products. They emphasize quality through GMP compliance and structural methodologies. Based in Hyderabad, Telangana, and Bidar, Karnataka, India, the company focuses on research, development, and production for the pharmaceutical industry.
- Headquarters Hyderabad, India
- Employees 80
- Founders A Prashant, K S Chowdary
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website azakemlabs.com
- Legal Name Azakem Labs Private Limited
- Date of Incorporation 17 Nov, 2005
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹47.09 Cr
FY 2025 · -8% YoY
- Net Profit₹7.05 Cr
FY 2025 · 15% margin
- EBITDA₹10.88 Cr
FY 2025 · 23% margin
- Employee Count80
Associated legal entities of Azakem Labs
Azakem Labs operates through Azakem Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Azakem Labs Private Limited CIN U24239TG2005PTC048093 | Active | 17 Nov 2005 | Hyderabad, Telangana | ₹47.1 Cr | 80 | 5 | View details |
Products & Services of Azakem Labs
Azakem Labs offers a comprehensive portfolio of products and services, including Almotriptan Malate, Eletriptan Hydrobromide, Anastrozole, API Manufacturing, and Research and Development.
Active ingredient for treating migraine symptoms effectively.
API used for migraine relief and pain management.
Compound for cancer treatment and hormonal therapy.
Service for synthesizing pharmaceutical bulk chemicals.
Process for developing new drug intermediates and methods.
Board of directors of Azakem Labs Private Limited (Azakem Labs)
Azakem Labs Private Limited is the primary company behind Azakem Labs. The board of Azakem Labs Private Limited currently have 5 directors; the longest-serving is Srinivasulu Chowdary Kavuturu, appointed in 2006. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Srinivasulu Chowdary Kavuturu DIN 00030543 | Managing Director | 23 Aug 2006 | 20 yrs 1 mo | Azakem Labs Private Limited |
| Ramesh Betini DIN 08814790 | Director | 31 Oct 2020 | 5 yrs 11 mo | Azakem Labs Private Limited |
| Kavuturu Harshavardhan DIN 08721115 | Director | 31 Oct 2020 | 5 yrs 11 mo | Azakem Labs Private Limited |
| Satish Bethini DIN 09127760 | Director | 30 Mar 2021 | 5 yrs 6 mo | Azakem Labs Private Limited |
| Kangani Cyrous DIN 09616702 | Director | 27 May 2022 | 4 yrs 4 mo | Azakem Labs Private Limited |
People of Azakem Labs
2 people are tracked at Azakem Labs (2 in leadership); the tracked headcount is 80.
| Name | Role | Group |
|---|---|---|
A Prashant | Co-Founder | Leadership |
K S Chowdary | Co-Founder | Leadership |
Complete people profiles for Azakem Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Azakem Labs
Figures of Azakem Labs Private Limited, the primary company behind Azakem Labs, for FY 2025. Revenue was ₹47.09 Cr (-8% year on year). Net profit was ₹7.05 Cr (15% margin). EBITDA was ₹10.88 Cr (23% margin). Revenue has grown at a compounded annual rate of +10% over three years and +17% over five years.
- ₹47.09 CrRevenue · FY 2025 · -8% YoY
- ₹7.05 CrNet profit · 15% margin
- ₹10.88 CrEBITDA · 23% margin
- ₹1.40 CrPaid-up capital
- 80Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Azakem Labs Private Limited are on its company page.
Detailed financial statements for Azakem Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Azakem Labs
Azakem Labs has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed similar companies of Azakem Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Azakem Labs (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Azakem Labs
Azakem Labs was founded in 2005.
Azakem Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Azakem Labs has 80 employees.
The primary company behind Azakem Labs, Azakem Labs Private Limited, reported revenue of ₹47.09 Cr for FY 2025, down 8% year on year.
Azakem Labs Private Limited, established in 2005, is a manufacturing company specializing in active pharmaceutical ingredients and their intermediates for categories like anti-migraine and anti-bacterial products. They emphasize quality through GMP compliance and structural methodologies. Based in Hyderabad, Telangana, and Bidar, Karnataka, India, the company focuses on research, development, and production for the pharmaceutical industry.
Azakem Labs's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Azakem Labs offers Almotriptan Malate, Eletriptan Hydrobromide, Anastrozole, API Manufacturing, and Research and Development.
Azakem Labs operates through Azakem Labs Private Limited.
The legal entities of Azakem Labs currently have 5 directors, including Kangani Cyrous, Ramesh Betini, Kavuturu Harshavardhan and others.